肝细胞癌免疫治疗的现状和未来方向

StephenW

Current Status and Future Directions for Immunotherapy in Hepatocellular Carcinoma

Ghassan K. Abou-Alfa, MD, MBA
Peter R. Galle, MD, PhD
Bruno Sangro, MD, PhD

肝细胞癌免疫治疗的现状和未来方向

医学博士Ghassan K.Abou-Alfa
彼得·加勒（Peter R.Galle），医学博士
医学博士Bruno Sangro

下载此幻灯片集https://www.clinicaloptions.com/ ... utm_source=hs_email以利用ICI对HCC进行最佳管理，包括：

     早期或中期HCC患者使用基于免疫检查点抑制剂的治疗方法的临床数据

     根据临床情况，使用基于免疫检查点抑制剂的方案针对晚期或转移性肝癌患者的最佳个性化治疗方法

     识别和缓解与HCC免疫检查点抑制剂疗法相关的独特不良事件的策略

    Clinical data on the use of immune checkpoint inhibitor–based treatment approaches for patients with early or intermediate-stage HCC

    Optimal, individualized therapy approaches using immune checkpoint inhibitor–based regimens for patients with advanced or metastatic HCC, as clinically appropriate

    Strategies to identify and mitigate unique adverse events associated with immune checkpoint inhibitor therapy in patients with HCC

ONC_Download_Slides_button